01 1Zhejiang Medicine Co Ltd
01 1RIFAXIMIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-07-22
Pay. Date : 2023-12-19
DMF Number : 39116
Submission : 2023-11-29
Status : Active
Type : II
20
Zhejiang Medicine Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIFAXIMIN, with a corresponding US DMF Number 39116.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 22, 2025, and payment made on December 19, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
